These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Bimodal impact of skeletal muscle on pancreatic β-cell function in health and disease. Plomgaard P; Halban PA; Bouzakri K Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():78-84. PubMed ID: 22928567 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population. Javor J; Ferencik S; Bucova M; Stuchlikova M; Martinka E; Barak L; Strbova L; Grosse-Wilde H; Buc M Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):385-93. PubMed ID: 20686866 [TBL] [Abstract][Full Text] [Related]
25. Cytokine Gene Variants as Predictors of Type 2 Diabetes Mellitus. Saxena M; Srivastava N; Banerjee M Curr Diabetes Rev; 2018; 14(3):307-319. PubMed ID: 28081697 [TBL] [Abstract][Full Text] [Related]
26. IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches. Elahi R; Nazari M; Mohammadi V; Esmaeilzadeh K; Esmaeilzadeh A Mol Immunol; 2024 Jul; 171():66-76. PubMed ID: 38795686 [TBL] [Abstract][Full Text] [Related]
27. Targeting innate immune mediators in type 1 and type 2 diabetes. Donath MY; Dinarello CA; Mandrup-Poulsen T Nat Rev Immunol; 2019 Dec; 19(12):734-746. PubMed ID: 31501536 [TBL] [Abstract][Full Text] [Related]
28. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial. Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882 [TBL] [Abstract][Full Text] [Related]
29. β-Cell inflammation in human type 2 diabetes and the role of autophagy. Marselli L; Bugliani M; Suleiman M; Olimpico F; Masini M; Petrini M; Boggi U; Filipponi F; Syed F; Marchetti P Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():130-6. PubMed ID: 24003929 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of beta-cell death in type 2 diabetes. Donath MY; Ehses JA; Maedler K; Schumann DM; Ellingsgaard H; Eppler E; Reinecke M Diabetes; 2005 Dec; 54 Suppl 2():S108-13. PubMed ID: 16306327 [TBL] [Abstract][Full Text] [Related]
31. Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Rehman K; Akash MSH; Liaqat A; Kamal S; Qadir MI; Rasul A Crit Rev Eukaryot Gene Expr; 2017; 27(3):229-236. PubMed ID: 29199608 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet. Abderrazak A; El Hadri K; Bosc E; Blondeau B; Slimane MN; Büchele B; Simmet T; Couchie D; Rouis M J Pharmacol Exp Ther; 2016 Jun; 357(3):487-94. PubMed ID: 27044804 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. Steer SA; Scarim AL; Chambers KT; Corbett JA PLoS Med; 2006 Feb; 3(2):e17. PubMed ID: 16354107 [TBL] [Abstract][Full Text] [Related]
34. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Testa R; Olivieri F; Bonfigli AR; Sirolla C; Boemi M; Marchegiani F; Marra M; Cenerelli S; Antonicelli R; Dolci A; Paolisso G; Franceschi C Diabetes Res Clin Pract; 2006 Mar; 71(3):299-305. PubMed ID: 16140413 [TBL] [Abstract][Full Text] [Related]
37. Pathology: Cause and effect. Jonietz E Nature; 2012 May; 485(7398):S10-11. PubMed ID: 22616098 [No Abstract] [Full Text] [Related]